Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules targeting central nervous system disorders and inflammatory diseases. Its structure supports the formation of hydrogen bonds and π-π interactions, enhancing binding affinity to specific enzyme active sites. Commonly employed in medicinal chemistry for lead optimization due to its favorable solubility and metabolic stability. Also utilized in the preparation of prodrugs where the tert-butyl carbamate group acts as a protecting group that can be cleaved under mild acidic conditions in vivo.